QGEN
NYEQiagen N.V.
Healthcare•Diagnostics & Research
Watchlists:
Last updated: Monday 21st July 2025
48.36
+0.12 (0.25%)
Prev Close:48.24
Open:48.7
Bid:47.38
Ask:49.35
52 Week Range
37.6348.90
Volume:1,358,312
Mkt Cap:10,255 M
55
MarketXLS Rank ®
Hold
Price Target
$55.61
+15.0%
Valuation
0.00
Range data not available
Returns
0.17%
3.42%
19.47%
11.05%
-6.02%
-5.64%
8.60%
Risk
Risk Metrics
Financial Scores
0.00
0.00
Ranks
Financial Scores
Risk Metrics
Dividends
Dividend Metrics
Dividend Yields
Dividend Dates
Analyst Estimates
EPS Estimates
Target Prices
Growth Estimates
Financial Health
Cash Metrics
Liquidity Ratios
0.00
0.00
Debt Metrics
Other Metrics
Financial Scores
Technicals
Technical Oscillators
Moving Averages
Volatility Metrics
Growth
EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A
Profitability
Margin Ratios
Financial Scores
Peers
Financial Statements
QGEN - Income Statement (Annual)
| Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Allowances For Construction | 734 M | |||||||||
| Depletion | 60 M | 67 M | 63 M | 72 M | 57 M | |||||
| Depreciation And Amortization | 68 M | 75 M | -89 M | 574 M | -86 M | -88 M | -216 M | -213 M | ||
| Earnings From Equity Interest | 4 M | 5 M | 2 M | 3 M | 3 M | 3 M | 661000.0 | |||
| Earnings From Equity Interest Net Of Tax | 4 M | 5 M | 2 M | 3 M | 3 M | 3 M | 661000.0 | |||
| Excise Taxes | 444 M | |||||||||
| Gain On Sale Of Security | 3 M | -1 M | 1 M | -6 M | ||||||
| General And Administrative Expense | 113 M | 119 M | 130 M | 128 M | 112 M | 112 M | 105 M | -24 M | -22 M | -23 M |
| Gross Profit Margin (profit Margin After CGS) | 1,026 M | 1,298 M | 1,385 M | 1,451 M | 1,233 M | 1,005 M | 1,001 M | 923 M | 845 M | 827 M |
| Impairment Of Capital Assets | -11 M | -7 M | -145 M | 8 M | -14 M | -9 M | -5 M | |||
| Interest Expense Non Operating | 44 M | 53 M | 58 M | 54 M | 71 M | 74 M | 67 M | 50 M | 39 M | 37 M |
| Minority Interests | 101000.0 | 246000.0 | ||||||||
| Misc Other Special Charges | -739000.0 | -6 M | 7 M | 41 M | 114 M | 432000.0 | 6 M | -4000.0 | -10 M | -11 M |
| Net Income (loss) | 84 M | 341 M | 423 M | 513 M | 359 M | -41 M | 190 M | 40 M | 80 M | 130 M |
| Net Income Common Stockholders | 84 M | 341 M | 423 M | 513 M | 359 M | -41 M | 190 M | 40 M | 80 M | 130 M |
| Net Income Continuous Operations | 84 M | 341 M | 423 M | 513 M | 359 M | -41 M | 190 M | 40 M | 80 M | 130 M |
| Net Income Discontinuous Operations | 6 M | |||||||||
| Net Non Operating Interest Income Expense | 24 M | 26 M | -26 M | -45 M | -61 M | -52 M | -46 M | -39 M | -32 M | -33 M |
| Normalized Income | 222 M | 351 M | ||||||||
| Operating Income | 200 M | 445 M | 531 M | 1,364 M | 386 M | -26 M | 275 M | 153 M | 99 M | 179 M |
| Operating Income Before Depreciation (EBITDA) | 387 M | 719 M | 779 M | 895 M | 716 M | 269 M | 535 M | 405 M | 329 M | 385 M |
| Operating Expense | 826 M | 853 M | 808 M | -821 M | -846 M | -1,031 M | -734 M | -769 M | -746 M | -647 M |
| Other Costof Revenue | 952 M | 667 M | ||||||||
| Other Gand A | 113 M | 119 M | 130 M | 128 M | 112 M | 112 M | 105 M | -24 M | -22 M | -23 M |
| Other Impairment Of Capital Assets | -13 M | 574 M | -40 M | -5 M | -21 M | -205000.0 | ||||
| Other Operating Expenses | 59 M | 46 M | 172 M | 370 M | 68 M | 239 M | 220 M | 141 M | ||
| Other Taxes | 450 M | |||||||||
| Other Write Off | -3 M | -10 M | -6 M | -3 M | -3 M | -2 M | -2 M | |||
| Promotion And Advertising | -16 M | -9 M | -8 M | -8 M | -7 M | -8 M | -7 M | |||
| Provision For Gain Loss On Disposal | 6 M | |||||||||
| Rent And Landing Fees | 130 M | 128 M | 112 M | 112 M | 105 M | -24 M | -22 M | -23 M | ||
| Research Expense | 193 M | 199 M | 190 M | 190 M | 149 M | 157 M | 162 M | 154 M | 150 M | 147 M |
| Restructring And Mn A Income | 102 M | 35 M | -79 M | |||||||
| Salaries And Wages | -49 M | -41 M | -66 M | -40 M | -34 M | -28 M | -24 M | |||
| Selling And Marketing Expense | 451 M | 460 M | 474 M | 456 M | 414 M | 392 M | 392 M | 376 M | 376 M | 360 M |
| Selling Expense | 474 M | 456 M | 414 M | 392 M | 392 M | 376 M | 376 M | 360 M | ||
| Total Income Available For Interest Expense (EBIT) | 165 M | 483 M | 571 M | 680 M | 511 M | -4 M | 293 M | 164 M | 96 M | 174 M |
| Total Revenues | 1,978 M | 1,965 M | 2,142 M | 2,252 M | 1,870 M | 1,526 M | 1,502 M | 1,418 M | 1,338 M | 1,281 M |
| Total Expenses | 1,778 M | 1,520 M | 1,565 M | -1,622 M | -1,484 M | -1,553 M | -1,235 M | -1,264 M | -1,239 M | -1,101 M |
| Total Revenue | 1,978 M | 1,965 M | 2,142 M | 2,252 M | 1,870 M | 1,526 M | 1,502 M | 1,418 M | 1,338 M | 1,281 M |
| Amord | 68 M | 75 M | -94 M | -104 M | -103 M | -123 M | -119 M | -159 M | -138 M | -132 M |
| Avgshs | 223 M | 228 M | 228 M | 228 M | 215 M | 214 M | 214 M | 215 M | 221 M | 212 M |
| Avgshsdt | 225 M | 231 M | 230 M | 232 M | 221 M | 214 M | 220 M | 220 M | 225 M | 215 M |
| Basiceps | 0.38 | 1.5 | 1.86 | 2.25 | 1.66 | -0.19 | 0.89 | 0.19 | 0.36 | 0.59 |
| Basicepscont | 0.38 | 1.5 | ||||||||
| Cor | 952 M | 667 M | 757 M | -801 M | -638 M | -521 M | -501 M | -495 M | -493 M | -454 M |
| Depamor | 68 M | 75 M | 60 M | 67 M | 638 M | 72 M | 57 M | -216 M | -213 M | |
| Dileps | 0.37 | 1.48 | 1.84 | 2.21 | 1.62 | -0.19 | 0.87 | 0.18 | 0.36 | 0.59 |
| Dilepscont | 0.37 | 1.48 | ||||||||
| Intinc | 68 M | 79 M | 33 M | 10 M | 10 M | 22 M | 21 M | 11 M | 7 M | 5 M |
| Netincdisc | 84 M | 341 M | 423 M | 513 M | 359 M | -41 M | 190 M | 40 M | 80 M | 130 M |
| Othincexp | 739000.0 | 6 M | -38 M | 693 M | -114 M | -432000.0 | -6 M | 4000.0 | 10 M | 11 M |
| Pretaxinc | 121 M | 430 M | 513 M | 626 M | 439 M | -78 M | 226 M | 114 M | 57 M | 136 M |
| Resdev | 193 M | 199 M | 190 M | 190 M | 149 M | 157 M | 162 M | 154 M | 150 M | 147 M |
| Restruct | 102 M | 35 M | -79 M | |||||||
| Sga | 564 M | 579 M | 604 M | 584 M | 525 M | 504 M | 497 M | 376 M | 376 M | 360 M |
| Shsout | 224 M | 216 M | 228 M | 227 M | 215 M | 215 M | 213 M | 214 M | 221 M | 212 M |
| Specincchg | -102 M | -35 M | 11 M | 7 M | 145 M | -8 M | 14 M | 9 M | 5 M | |
| Taxprov | 38 M | 89 M | 89 M | 113 M | 80 M | -36 M | 35 M | 74 M | -23 M | 6 M |